Merck & Co., Inc. — Director's Dealing 2014

Feb 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-02-11

Reporting Person: FRAZIER KENNETH C (Director, Chairman, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-11	Common Stock	M	45000.0000	$48.2400	Acquired	304349.0630	Direct
2014-02-11	Common Stock	S	41520.0000	$54.5203	Disposed	262829.0630	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-11	Stock Option (right to buy)	$48.2400	M	45000.0000	Disposed	2014-02-26	Common Stock (45000.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock - 401(k) Plan	3445.3457	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.47 to $54.60, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.

F2: Holdings include shares acquired in dividend reinvestment transactions.

F3: Includes shares acquired and dividends through January 8, 2014, in the Merck U.S. Savings Plan, a 401(k) plan.